GLYPICAN-3

Clinical trials for GLYPICAN-3 explained in plain language.

Never miss a new study

Get alerted when new GLYPICAN-3 trials appear

Sign up with your email to follow new studies for GLYPICAN-3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New imaging agent could sharpen liver cancer detection

Diagnosis Recruiting now

This study tests a new radioactive tracer called 68Ga-GPC3 that targets a protein found on liver cancer cells. About 40 adults with suspected or confirmed hepatocellular carcinoma will receive both this new tracer and a standard tracer (18F-FDG) for PET/CT scans. Researchers will…

Matched conditions: GLYPICAN-3

Phase: NA • Sponsor: The First Affiliated Hospital of Xiamen University • Aim: Diagnosis

Last updated Jul 02, 2026 03:00 UTC

GLYPICAN-3

Get alerted when new GLYPICAN-3 trials appear

New imaging agent could sharpen liver cancer detection